Mammography Market

SKU: DMMI127 | Last Updated On: Sep 21 2022 | Available Formats

>Mammography Market Expected to reach a high CAGR of 11.50% during the forecast period 2022-2029:

Mammography Market is segmented By Type (Digital Mammography, Analog Mammography, Diagnostic Mammography, and Others), By Dimension (2D, 3D, Combined), By Application (Oncology and Others), By End-User (Diagnostic Centres, Hospitals and Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029. 

Mammography Market is expected to grow at a CAGR 11.50% during the forecasting period 2022-2029. Mammography facilitates the detection of breast cancer. These tests are used for screening and diagnosis of breast cancer among women. They can also be used to detect and diagnose breast disease in women experiencing symptoms such as a lump, pain, skin dimpling or nipple discharge.

Mammography Market Dynamics

Mammography Market growth is driven by the increasing instances of breast cancer in women across the globe, advancements in identification and treatment methods of cancer and growing health concerns and government initiatives.  

The introduction of new products in the market will drive the market growth

The introduction of new products in the market is expected to drive the adoption rate among end-users. The earlier generations of mammography systems provided 2D images of the breast, which limits the interpretation quality. 2D mammography systems provide Craniocaudal (CC) and Mediolateral-Oblique (MLO) images. The flat nature of these images makes it difficult for physicians to interpret images and identify tumors due to overlapping of tissues and calcifications, which masks cancerous lesions. With the introduction of new 3D-based technology called Digital Breast Tomosynthesis (DBT), it is possible to obtain a 3D image of the breast. This allows radiologists to scan the breast slice by slice and identify abnormalities, which would be obscured in 2D images.

According to the Centers for Disease Control and Prevention (CDC) reports 2018, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third-most-common cause of death from cancer among American Indian/Alaska Native women.

According to a Globocan report in 2020, breast cancer was the most prevalent type of cancer, with a prevalence rate of 11.7%. According to the same report, the five-year prevalence rate for both the sexes showed that Asia had the highest number of people affected at 3,218,496 (41.3%), followed by Europe at 2,138,117 (27.4%) and North America with 1.189,111 people (15.3%). Such high prevalence rates of breast cancer are one of the main reasons the demand for mammography devices is expected to increase, as they may be used for diagnostic purposes. Furthermore, as the global population is aging, a large number of women are expected to move into the age of 60 years and above. Women aged 60 years and above account for almost 78% of all breast cancer-related deaths. High incidence and mortality rates for breast cancer in this age group represent a huge unmet need for breast cancer diagnostics. As the number of incidents and mortality cases increases, the demand for mammography is also expected to increase. This remains a major driver for the mammography market and is expected to drive the market during the forecast period.   

Adverse effects from radiation exposure is likely to hamper the market growth  

However, adverse effects from radiation exposure and risks associated with mammography are expected to pull back the market growth over the forecast period. 

COVID-19 Impact Analysis

Due to the outbreak of COVID-19, the market is expected to face a slight setback owing to the delay in diagnosis, drug shortages, and others. As many hospitals and screening centers remain closed due to lockdowns, the demand for mammography procedures is expected to be subdued in the short term. According to an article appearing in the JAMA Network in August 2020, there has been a significant decline in breast cancer diagnoses (by as much as 51.8%) in the United States from March 1, 2020, to April 18, 2020. Thus, this is expected to have a negative impact on mammography device manufacturers, as their demand has reduced significantly.

However, as lockdowns and restrictions are getting relaxed, there may be an increase in demand for mammography services. Many women who had canceled their appointments or had their visits for mammography services postponed are now able to get their tests done. The Breast Cancer Research Foundation in the United States has stated that hospitals and facilities in most places are well prepared and safe now as compared to the initial days of the COVID-19 pandemic. Thus, it has been encouraging women to get their scheduled scans done so that diagnosis is not delayed.

Mammography Market Segment Analysis

The digital mammography segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)     

Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. Previously, conventional screen-film mammography (SFM) with the high-spatial-resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with the added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as the United Kingdom, is now digital, offering greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.

Moreover, as per the American Cancer Society, in 2019, there were around 8,130 Ductal carcinomas in situ (DCIS) and 37,150 invasive breast cancer new cases among females aged between 40 to 49 years reported in the United States. Thus, the rising prevalence of breast cancer is likely to boost the demand for digital mammography.

Mammography Market

Metrics

Details

Market CAGR

11.50%

Segments Covered

By Type, By Dimension, By Application, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Mammography Market Geographical Analysis

North America region holds the largest market share of global mammography market

North America is found to hold a major share of the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.

According to the American Cancer Society, in 2020, an estimated 276,480 new cases of invasive breast cancer have been diagnosed among women. Additionally, 48,530 cases of in situ breast carcinoma have been diagnosed among women, and the number of breast cancer cases is expected to increase in the coming years. Furthermore, several companies are found launching programs to support breast cancer tests. For instance, in August 2020, Hologic Inc. announced the Back to screening campaign launch, which may encourage women to schedule their delayed mammograms due to the COVID-19 pandemic. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond the Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth in the region.

Mammography Market Competitive Landscape

The mammography market is highly competitive with presence of local as well as global companies.  Some of the key players which are contributing to the growth of the market include Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., General Medical Merate SpA, Koninklijke Philips NV, Metaltronica SpA, Konica Minolta Inc., Planmed Oy, Siemens Healthineers, Carestream Health, and Canon Medical Systems among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the mammography market globally. For instance in November 2020, Hologic Inc. and RadNet announced a collaboration to advance the development of artificial intelligence tools in breast health. The collaboration may include data sharing, R&D, and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology.

Siemens Healthineers

Overview: Siemens Healthineers AG is a Germany-based company that supplies technology to the healthcare industry. The Company offers a wide range of products and services in the fields of diagnostic and therapeutic imaging, laboratory and point of care diagnostics, and molecular medicine.  

Product Portfolio:

Insight 2D:  Insight 2D, offers breast images with an FFDM-like image impression. This allows you to perform fast comparison and easy breast density evaluation without the added dose of an additional 2D examination. Insight 2D eases the transition from FFDM to tomosynthesis as it takes the 2D viewing and reading habits of radiologists into account.

Frequently Asked Questions

What is the Projected CAGR value of the Mammography Market?

Mammography Market is expected to grow at a CAGR of11.50% during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America region Controls the Mammography Market during 2022-2029

Which is the fastest growing region in the Mammography Market?

Among all regions, Asia Pacific is the fastest growing market share during the forecast period

Trending Topics

Electrocardiograph (ECG) Market

Ultrasound devises Market

Nuclear Imaging Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest